Pharmacokinetic and pharmacodynamic modeling of pegylated-interferon alfa.
Dimova
Rositsa B
RB
Talal
Andrew H
AH
D000998:Antiviral Agents / Q000493:pharmacokinetics* / Q000494:pharmacology*; D016174:Hepacivirus / Q000187:drug effects; D006526:Hepatitis C / Q000188:drug therapy / Q000378:metabolism / Q000821:virology; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000493:pharmacokinetics* / Q000494:pharmacology*; D008954:Models, Biological; D011092:Polyethylene Glycols / Q000493:pharmacokinetics* / Q000494:pharmacology*; D012367:RNA, Viral / Q000097:blood; D011994:Recombinant Proteins
D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D012367:RNA, Viral; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; C417083:peginterferon alfa-2b; C100416:peginterferon alfa-2a